Dr. Yeissen Godinez, MD

Dr. Godinez practices at HCA Florida Kendall Hospital in Miami, Florida, part of HCA Healthcare.

Dr. Godinez's NPI, 1871988873, was assigned on April 6, 2015. Dr. Godinez graduated from Ross University School of Medicine in 2014. Dr. Godinez holds Florida license ME137053.

Dr. Godinez's primary practice is HCA Florida Kendall Hospital, at 11750 Bird Rd, Miami, FL 33175 in Miami-Dade County. The practice phone is (305) 223-3000.

Dr. Godinez's primary practice is HCA Florida Kendall Hospital in Miami, Florida, part of HCA Healthcare. Dr. Godinez is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Hospital Medicine Services of Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Godinez practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Godinez's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Godinez is board certified in internal medicine by the American Board of Internal Medicine. Dr. Godinez is licensed in Florida.

Dmand AI lists acute stomach ulcer, atrial fibrillation and flutter, chronic anemia, chronic hypertension, chronic kidney disease, circulation problems, congestive heart failure and coronary artery disease among the conditions Dr. Godinez treats.

CMS data shows 397 Medicare services from Dr. Godinez across 8 procedure codes in 2024, for 117 Medicare patients. Medicare paid $34,981 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Dr. Godinez in 2024. The largest group is 85 and over, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 73% are also on Medicaid. Their average risk score is 3.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Godinez's median patient age at 63, with 52% women.

In 2024, Dr. Godinez wrote 77 Medicare Part D claims for 28 patients. 87% of them were for generic drugs. They cover 5 drugs, with $10,878 in total drug cost. In 2019, CMS named 221 claims across 11 drugs.

Dr. Godinez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Godinez in 2020. Dr. Godinez's most frequent co-author is Mark G. McKenney, MD.

CMS Open Payments shows 46 general payments to Dr. Godinez from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Shionogi Inc paid the most, $1,191.

Dmand AI lists 7 awards for Dr. Godinez, most recently Faculty of the Year / TY Residency in 2021. Dr. Godinez serves on Sepsis Committee, Candidate Selection Committee and Clinical Competency Committee.

Dr. Godinez graduated from Ross University School of Medicine in 2014. Dr. Godinez is a member of AAIM, American Association for Clinical Chemistry, ACP, AMA and Society of Hospital Medicine.

Dr. Godinez is in network with 5 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.